[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Oligonucleotide Pool Library Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

April 2024 | 137 pages | ID: GD286357F44CEN
APO Research

US$ 4,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
North America occupied the largest market share with about 40%. It was followed by Europe?with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

According to APO Research, The global Oligonucleotide Pool Library market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North America occupied the largest market share with about 40%. It was followed by Europe?with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, and they had a more than 40% combined market share.

This report presents an overview of global market for Oligonucleotide Pool Library, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Oligonucleotide Pool Library, also provides the value of main regions and countries. Of the upcoming market potential for Oligonucleotide Pool Library, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oligonucleotide Pool Library revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oligonucleotide Pool Library market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Descriptive company profiles of the major global players, including Agilent, Eurogentec S.A, Sigmaaldrich, Illumnia, L.G.C Biosearch Technologies, Eurofins Genomics, Roche NimbleGe, Integrated DNA Technologies and Nitto Denko Avecia Inc, etc.

Oligonucleotide Pool Library segment by Company
  • Agilent
  • Eurogentec S.A
  • Sigmaaldrich
  • Illumnia
  • L.G.C Biosearch Technologies
  • Eurofins Genomics
  • Roche NimbleGe
  • Integrated DNA Technologies
  • Nitto Denko Avecia Inc
  • General Biosystems
  • MYcroarray
  • Twist Bioscience
  • CustomArray
  • LC Sciences
  • Creative Biogene
Oligonucleotide Pool Library segment by Type
  • DNA Oligos
  • RNA Oligos
Oligonucleotide Pool Library segment by Application
  • Target Capture
  • CRISPR/Cas9 Designs
  • Gene Synthesis
  • Library Preparation
  • Others
Oligonucleotide Pool Library segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global Oligonucleotide Pool Library status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Oligonucleotide Pool Library key companies, revenue, market share, and recent developments.

3. To split the Oligonucleotide Pool Library breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Oligonucleotide Pool Library market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oligonucleotide Pool Library significant trends, drivers, influence factors in global and regions.

6. To analyze Oligonucleotide Pool Library competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Pool Library market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Pool Library and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Pool Library.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oligonucleotide Pool Library industry.

Chapter 3: Detailed analysis of Oligonucleotide Pool Library company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Oligonucleotide Pool Library in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Oligonucleotide Pool Library in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

Chapter 9: Concluding Insights.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Oligonucleotide Pool Library Market Size, 2019 VS 2023 VS 2030
1.3 Global Oligonucleotide Pool Library Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives

2 OLIGONUCLEOTIDE POOL LIBRARY MARKET DYNAMICS

2.1 Oligonucleotide Pool Library Industry Trends
2.2 Oligonucleotide Pool Library Industry Drivers
2.3 Oligonucleotide Pool Library Industry Opportunities and Challenges
2.4 Oligonucleotide Pool Library Industry Restraints

3 OLIGONUCLEOTIDE POOL LIBRARY MARKET BY COMPANY

3.1 Global Oligonucleotide Pool Library Company Revenue Ranking in 2023
3.2 Global Oligonucleotide Pool Library Revenue by Company (2019-2024)
3.3 Global Oligonucleotide Pool Library Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Oligonucleotide Pool Library Company Manufacturing Base & Headquarters
3.5 Global Oligonucleotide Pool Library Company, Product Type & Application
3.6 Global Oligonucleotide Pool Library Company Commercialization Time
3.7 Market Competitive Analysis
  3.7.1 Global Oligonucleotide Pool Library Market CR5 and HHI
  3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
  3.7.3 2023 Oligonucleotide Pool Library Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion

4 OLIGONUCLEOTIDE POOL LIBRARY MARKET BY TYPE

4.1 Oligonucleotide Pool Library Type Introduction
  4.1.1 DNA Oligos
  4.1.2 RNA Oligos
4.2 Global Oligonucleotide Pool Library Sales Value by Type
  4.2.1 Global Oligonucleotide Pool Library Sales Value by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Oligonucleotide Pool Library Sales Value by Type (2019-2030)
  4.2.3 Global Oligonucleotide Pool Library Sales Value Share by Type (2019-2030)

5 OLIGONUCLEOTIDE POOL LIBRARY MARKET BY APPLICATION

5.1 Oligonucleotide Pool Library Application Introduction
  5.1.1 Target Capture
  5.1.2 CRISPR/Cas9 Designs
  5.1.3 Gene Synthesis
  5.1.4 Library Preparation
  5.1.5 Others
5.2 Global Oligonucleotide Pool Library Sales Value by Application
  5.2.1 Global Oligonucleotide Pool Library Sales Value by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Oligonucleotide Pool Library Sales Value by Application (2019-2030)
  5.2.3 Global Oligonucleotide Pool Library Sales Value Share by Application (2019-2030)

6 OLIGONUCLEOTIDE POOL LIBRARY MARKET BY REGION

6.1 Global Oligonucleotide Pool Library Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Oligonucleotide Pool Library Sales Value by Region (2019-2030)
  6.2.1 Global Oligonucleotide Pool Library Sales Value by Region: 2019-2024
  6.2.2 Global Oligonucleotide Pool Library Sales Value by Region (2025-2030)
6.3 North America
  6.3.1 North America Oligonucleotide Pool Library Sales Value (2019-2030)
  6.3.2 North America Oligonucleotide Pool Library Sales Value Share by Country, 2023 VS 2030
6.4 Europe
  6.4.1 Europe Oligonucleotide Pool Library Sales Value (2019-2030)
  6.4.2 Europe Oligonucleotide Pool Library Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
  6.5.1 Asia-Pacific Oligonucleotide Pool Library Sales Value (2019-2030)
  6.5.2 Asia-Pacific Oligonucleotide Pool Library Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
  6.6.1 Latin America Oligonucleotide Pool Library Sales Value (2019-2030)
  6.6.2 Latin America Oligonucleotide Pool Library Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
  6.7.1 Middle East & Africa Oligonucleotide Pool Library Sales Value (2019-2030)
  6.7.2 Middle East & Africa Oligonucleotide Pool Library Sales Value Share by Country, 2023 VS 2030

7 OLIGONUCLEOTIDE POOL LIBRARY MARKET BY COUNTRY

7.1 Global Oligonucleotide Pool Library Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Oligonucleotide Pool Library Sales Value by Country (2019-2030)
  7.2.1 Global Oligonucleotide Pool Library Sales Value by Country (2019-2024)
  7.2.2 Global Oligonucleotide Pool Library Sales Value by Country (2025-2030)
7.3 USA
  7.3.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.3.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.3.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.4 Canada
  7.4.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.4.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.4.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.5 Germany
  7.5.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.5.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.5.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.6 France
  7.6.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.6.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.6.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
  7.7.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.7.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.7.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.8 Italy
  7.8.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.8.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.8.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
  7.9.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.9.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.9.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
  7.10.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.10.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.10.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.11 China
  7.11.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.11.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.11.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.12 Japan
  7.12.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.12.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.12.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
  7.13.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.13.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.13.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
  7.14.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.14.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.14.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.15 India
  7.15.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.15.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.15.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.16 Australia
  7.16.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.16.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.16.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
  7.17.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.17.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.17.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
  7.18.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.18.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.18.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
  7.19.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.19.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.19.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
  7.20.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.20.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.20.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030
7.21 UAE
  7.21.1 Global Oligonucleotide Pool Library Sales Value Growth Rate (2019-2030)
  7.21.2 Global Oligonucleotide Pool Library Sales Value Share by Type, 2023 VS 2030
  7.21.3 Global Oligonucleotide Pool Library Sales Value Share by Application, 2023 VS 2030

8 COMPANY PROFILES

8.1 Agilent
  8.1.1 Agilent Comapny Information
  8.1.2 Agilent Business Overview
  8.1.3 Agilent Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.1.4 Agilent Oligonucleotide Pool Library Product Portfolio
  8.1.5 Agilent Recent Developments
8.2 Eurogentec S.A
  8.2.1 Eurogentec S.A Comapny Information
  8.2.2 Eurogentec S.A Business Overview
  8.2.3 Eurogentec S.A Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.2.4 Eurogentec S.A Oligonucleotide Pool Library Product Portfolio
  8.2.5 Eurogentec S.A Recent Developments
8.3 Sigmaaldrich
  8.3.1 Sigmaaldrich Comapny Information
  8.3.2 Sigmaaldrich Business Overview
  8.3.3 Sigmaaldrich Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.3.4 Sigmaaldrich Oligonucleotide Pool Library Product Portfolio
  8.3.5 Sigmaaldrich Recent Developments
8.4 Illumnia
  8.4.1 Illumnia Comapny Information
  8.4.2 Illumnia Business Overview
  8.4.3 Illumnia Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.4.4 Illumnia Oligonucleotide Pool Library Product Portfolio
  8.4.5 Illumnia Recent Developments
8.5 L.G.C Biosearch Technologies
  8.5.1 L.G.C Biosearch Technologies Comapny Information
  8.5.2 L.G.C Biosearch Technologies Business Overview
  8.5.3 L.G.C Biosearch Technologies Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.5.4 L.G.C Biosearch Technologies Oligonucleotide Pool Library Product Portfolio
  8.5.5 L.G.C Biosearch Technologies Recent Developments
8.6 Eurofins Genomics
  8.6.1 Eurofins Genomics Comapny Information
  8.6.2 Eurofins Genomics Business Overview
  8.6.3 Eurofins Genomics Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.6.4 Eurofins Genomics Oligonucleotide Pool Library Product Portfolio
  8.6.5 Eurofins Genomics Recent Developments
8.7 Roche NimbleGe
  8.7.1 Roche NimbleGe Comapny Information
  8.7.2 Roche NimbleGe Business Overview
  8.7.3 Roche NimbleGe Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.7.4 Roche NimbleGe Oligonucleotide Pool Library Product Portfolio
  8.7.5 Roche NimbleGe Recent Developments
8.8 Integrated DNA Technologies
  8.8.1 Integrated DNA Technologies Comapny Information
  8.8.2 Integrated DNA Technologies Business Overview
  8.8.3 Integrated DNA Technologies Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.8.4 Integrated DNA Technologies Oligonucleotide Pool Library Product Portfolio
  8.8.5 Integrated DNA Technologies Recent Developments
8.9 Nitto Denko Avecia Inc
  8.9.1 Nitto Denko Avecia Inc Comapny Information
  8.9.2 Nitto Denko Avecia Inc Business Overview
  8.9.3 Nitto Denko Avecia Inc Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.9.4 Nitto Denko Avecia Inc Oligonucleotide Pool Library Product Portfolio
  8.9.5 Nitto Denko Avecia Inc Recent Developments
8.10 General Biosystems
  8.10.1 General Biosystems Comapny Information
  8.10.2 General Biosystems Business Overview
  8.10.3 General Biosystems Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.10.4 General Biosystems Oligonucleotide Pool Library Product Portfolio
  8.10.5 General Biosystems Recent Developments
8.11 MYcroarray
  8.11.1 MYcroarray Comapny Information
  8.11.2 MYcroarray Business Overview
  8.11.3 MYcroarray Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.11.4 MYcroarray Oligonucleotide Pool Library Product Portfolio
  8.11.5 MYcroarray Recent Developments
8.12 Twist Bioscience
  8.12.1 Twist Bioscience Comapny Information
  8.12.2 Twist Bioscience Business Overview
  8.12.3 Twist Bioscience Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.12.4 Twist Bioscience Oligonucleotide Pool Library Product Portfolio
  8.12.5 Twist Bioscience Recent Developments
8.13 CustomArray
  8.13.1 CustomArray Comapny Information
  8.13.2 CustomArray Business Overview
  8.13.3 CustomArray Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.13.4 CustomArray Oligonucleotide Pool Library Product Portfolio
  8.13.5 CustomArray Recent Developments
8.14 LC Sciences
  8.14.1 LC Sciences Comapny Information
  8.14.2 LC Sciences Business Overview
  8.14.3 LC Sciences Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.14.4 LC Sciences Oligonucleotide Pool Library Product Portfolio
  8.14.5 LC Sciences Recent Developments
8.15 Creative Biogene
  8.15.1 Creative Biogene Comapny Information
  8.15.2 Creative Biogene Business Overview
  8.15.3 Creative Biogene Oligonucleotide Pool Library Revenue and Gross Margin (2019-2024)
  8.15.4 Creative Biogene Oligonucleotide Pool Library Product Portfolio
  8.15.5 Creative Biogene Recent Developments

9 CONCLUDING INSIGHTS

10 APPENDIX

10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
  10.5.1 Secondary Sources
  10.5.2 Primary Sources
10.6 Disclaimer


More Publications